| Year |
Citation |
Score |
| 2023 |
Palm RF, Boyer E, Kim DW, Denbo J, Hodul PJ, Malafa M, Fleming JB, Shridhar R, Chuong MD, Mellon EA, Frakes JM, Hoffe SE. Neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreas adenocarcinoma: influence of vascular margin status and type of chemotherapy. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. PMID 37286392 DOI: 10.1016/j.hpb.2023.04.019 |
0.311 |
|
| 2022 |
Shridhar R, Blinn P, Huston J, Meredith KL. Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis. Cancer. PMID 36544387 DOI: 10.1002/cncr.34625 |
0.327 |
|
| 2022 |
Takahashi C, Shridhar R, Huston J, Meredith K. Adjuvant therapy for margin positive pancreatic cancer: A propensity score matched analysis. Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]. PMID 35304103 DOI: 10.1016/j.pan.2022.03.008 |
0.34 |
|
| 2021 |
Takahashi C, Shridhar R, Huston J, Blinn P, Maramara T, Meredith K. Comparative outcomes of transthoracic versus transhiatal esophagectomy. Surgery. PMID 33894983 DOI: 10.1016/j.surg.2021.02.036 |
0.337 |
|
| 2020 |
Blinn P, Shridhar R, Maramara T, Huston J, Meredith K. Multi-agent neoadjuvant chemotherapy improves response and survival in patients with resectable pancreatic cancer. Journal of Gastrointestinal Oncology. 11: 1078-1089. PMID 33209499 DOI: 10.21037/Jgo.2019.12.03 |
0.426 |
|
| 2020 |
Alkayali T, Ricardo J, Salem AI, Huston J, Shridhar R, Meredith KL. Mo1022 PANCREATIC CANCER IN HISPANIC PATIENTS: A DEMOGRAPHIC ANALYSIS OF THE NATIONAL CANCER DATABASE Gastroenterology. 158: S-759-S-760. DOI: 10.1016/S0016-5085(20)32570-1 |
0.436 |
|
| 2019 |
Shridhar R, Takahashi C, Huston J, Meredith KL. Neoadjuvant therapy and pancreatic cancer: a national cancer database analysis. Journal of Gastrointestinal Oncology. 10: 663-673. PMID 31392047 DOI: 10.21037/Jgo.2019.02.09 |
0.462 |
|
| 2019 |
Salem AI, Alkayali T, Ricardo J, Shridhar R, Huston J, Meredith KL. Su1120 – Has Accuracy of Clinical Staging of T1N0M0 Esophageal Cancer Improved Over Time? a Hospital-Based Analysis from the National Cancer Database (NCDB) Gastroenterology. 156. DOI: 10.1016/S0016-5085(19)38152-1 |
0.379 |
|
| 2018 |
Nora I, Shridhar R, Huston J, Meredith K. The accuracy of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as a marker for gastrointestinal malignancies. Journal of Gastrointestinal Oncology. 9: 972-978. PMID 30505600 DOI: 10.21037/Jgo.2018.08.05 |
0.373 |
|
| 2018 |
Takahashi C, Shridhar R, Huston J, Meredith K. Outcomes associated with robotic approach to pancreatic resections. Journal of Gastrointestinal Oncology. 9: 936-941. PMID 30505596 DOI: 10.21037/Jgo.2018.08.04 |
0.35 |
|
| 2018 |
Takahashi C, Shridhar R, Huston J, Meredith K. Correlation of tumor size and survival in pancreatic cancer. Journal of Gastrointestinal Oncology. 9: 910-921. PMID 30505594 DOI: 10.21037/Jgo.2018.08.06 |
0.423 |
|
| 2018 |
Takahashi C, Shridhar R, Huston J, Meredith K. Esophagectomy from then to now. Journal of Gastrointestinal Oncology. 9: 903-909. PMID 30505593 DOI: 10.21037/Jgo.2018.08.15 |
0.398 |
|
| 2018 |
Shridhar R, Takahashi C, Huston J, Doepker MP, Meredith KL. Anastomotic leak and neoadjuvant chemoradiotherapy in esophageal cancer. Journal of Gastrointestinal Oncology. 9: 894-902. PMID 30505592 DOI: 10.21037/Jgo.2018.04.09 |
0.374 |
|
| 2018 |
Shridhar R, Huston J, Meredith KL. Accuracy of endoscopic ultrasound staging for T2N0 esophageal cancer: a National Cancer Database analysis. Journal of Gastrointestinal Oncology. 9: 887-893. PMID 30505591 DOI: 10.21037/Jgo.2018.01.16 |
0.405 |
|
| 2018 |
Takahashi C, Shridhar R, Huston J, Meredith K. Clinical fate of T0N1 esophageal cancer: results from the National Cancer Database. Journal of Gastrointestinal Oncology. 9: 880-886. PMID 30505590 DOI: 10.21037/Jgo.2018.08.08 |
0.46 |
|
| 2018 |
Jin WH, Hoffe SE, Shridhar R, Strom T, Venkat P, Springett GM, Hodul PJ, Pimiento JM, Meredith KL, Malafa MP, Frakes JM. Adjuvant radiation provides survival benefit for resected pancreatic adenocarcinomas of the tail. Journal of Gastrointestinal Oncology. 9: 487-494. PMID 29998014 DOI: 10.21037/Jgo.2018.02.02 |
0.457 |
|
| 2018 |
Takahashi C, Meredith K, Shridhar R, Huston J, Briceno P. Does a Dual Surgeon Approach to Pancreatic Resection Improve Outcome Journal of the American College of Surgeons. 227. DOI: 10.1016/J.Jamcollsurg.2018.08.580 |
0.331 |
|
| 2017 |
Saeed NA, Mellon EA, Meredith KL, Hoffe SE, Shridhar R, Frakes J, Fontaine JP, Pimiento JM, Kothari N, Almhanna K. Adjuvant chemotherapy and outcomes in esophageal carcinoma. Journal of Gastrointestinal Oncology. 8: 816-824. PMID 29184685 DOI: 10.21037/Jgo.2017.07.10 |
0.431 |
|
| 2017 |
Frakes J, Mellon EA, Springett GM, Hodul P, Malafa MP, Fulp WJ, Zhao X, Hoffe SE, Shridhar R, Meredith KL. Outcomes of adjuvant radiotherapy and lymph node resection in elderly patients with pancreatic cancer treated with surgery and chemotherapy. Journal of Gastrointestinal Oncology. 8: 758-765. PMID 29184679 DOI: 10.21037/jgo.2017.08.05 |
0.481 |
|
| 2017 |
Lee L, Kelly J, Nassif GJ, Atallah SB, Albert MR, Shridhar R, Monson JRT. Chemoradiation and Local Excision for T2N0 Rectal Cancer Offers Equivalent Overall Survival Compared to Standard Resection: a National Cancer Database Analysis. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. PMID 28819913 DOI: 10.1007/S11605-017-3536-5 |
0.445 |
|
| 2017 |
Abbott AM, Doepker MP, Kim Y, Perez MC, Gandle C, Thomas KL, Choi J, Shridhar R, Zager JS. Hepatic Progression-free and Overall Survival After Regional Therapy to the Liver for Metastatic Melanoma. American Journal of Clinical Oncology. PMID 28059929 DOI: 10.1097/Coc.0000000000000356 |
0.333 |
|
| 2016 |
Keller A, Ismail R, Potrebko PS, Pepe J, Wu M, Saigal K, Biagioli M, Shridhar R, Holloway R, Field M, Rao NG. Role of Gamma Knife® Radiosurgery for the Treatment of Brain Metastases from Gynecological Cancers. Cureus. 8: e947. PMID 28168125 DOI: 10.7759/Cureus.947 |
0.386 |
|
| 2016 |
Mellon EA, Jin WH, Frakes JM, Centeno BA, Strom TJ, Springett GM, Malafa MP, Shridhar R, Hodul PJ, Hoffe SE. Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy. Acta Oncologica (Stockholm, Sweden). 1-7. PMID 27885876 DOI: 10.1080/0284186X.2016.1256497 |
0.421 |
|
| 2016 |
Shridhar R, Huston J, Kucera S, Patel A, Brown R, Meredith K. Comparative Outcomes of Upfront Surgery, Neoadjuvant Chemoradiation, or Definitive Chemoradiation for T2N0M0 Esophageal Adenocarcinomas From The National Cancer Data Base. International Journal of Radiation Oncology, Biology, Physics. 96: S189-S190. PMID 27675745 DOI: 10.1016/J.Ijrobp.2016.06.473 |
0.412 |
|
| 2016 |
Kothari N, Mellon E, Hoffe SE, Frakes J, Shridhar R, Pimiento J, Meredith K, Tran ND, Saeed N, Almhanna K. Outcomes in patients with brain metastasis from esophageal carcinoma. Journal of Gastrointestinal Oncology. 7: 562-9. PMID 27563446 DOI: 10.21037/jgo.2016.03.12 |
0.351 |
|
| 2016 |
Mellon EA, Strom TJ, Hoffe SE, Frakes JM, Springett GM, Hodul PJ, Malafa MP, Chuong MD, Shridhar R. Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer. Journal of Gastrointestinal Oncology. 7: 547-55. PMID 27563444 DOI: 10.21037/Jgo.2016.03.15 |
0.5 |
|
| 2016 |
Almhanna K, Weber J, Shridhar R, Hoffe S, Strosberg J, Meredith K. Determining the optimal number of lymph nodes harvested during esophagectomy. Journal of Gastrointestinal Oncology. 7: 387-94. PMID 27284471 DOI: 10.21037/Jgo.2015.12.02 |
0.309 |
|
| 2016 |
Suker M, Beumer BR, Sadot E, Marthey L, Faris JE, Mellon EA, El-Rayes BF, Wang-Gillam A, Lacy J, Hosein PJ, Moorcraft SY, Conroy T, Hohla F, Allen P, Taieb J, ... ... Shridhar R, et al. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. The Lancet. Oncology. PMID 27160474 DOI: 10.1016/S1470-2045(16)00172-8 |
0.457 |
|
| 2016 |
Salem AI, Thau MR, Strom TJ, Abbott AM, Saeed N, Almhanna K, Hoffe SE, Shridhar R, Karl RC, Meredith KL. Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy: retrospective analysis of 129 cases at a single high-volume tertiary care center. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus / I.S.D.E. PMID 27149640 DOI: 10.1111/Dote.12484 |
0.335 |
|
| 2016 |
Chuong MD, Frakes JM, Figura N, Hoffe SE, Shridhar R, Mellon EA, Hodul PJ, Malafa MP, Springett GM, Centeno BA. Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer. Journal of Gastrointestinal Oncology. 7: 221-7. PMID 27034789 DOI: 10.3978/J.Issn.2078-6891.2015.075 |
0.498 |
|
| 2016 |
Shridhar R, Abbott AM, Doepker M, Hoffe SE, Almhanna K, Meredith KL. Perioperative outcomes associated with robotic Ivor Lewis esophagectomy in patient's undergoing neoadjuvant chemoradiotherapy. Journal of Gastrointestinal Oncology. 7: 206-12. PMID 27034787 DOI: 10.3978/J.Issn.2078-6891.2015.104 |
0.352 |
|
| 2016 |
Saeed N, Shridhar R, Hoffe S, Almhanna K, Meredith KL. AKT expression is associated with degree of pathologic response in adenocarcinoma of the esophagus treated with neoadjuvant therapy. Journal of Gastrointestinal Oncology. 7: 158-65. PMID 27034781 DOI: 10.3978/J.Issn.2078-6891.2015.067 |
0.326 |
|
| 2016 |
Kim R, Prithviraj GK, Shridhar R, Hoffe SE, Jiang K, Zhao X, Chen DT, Almhanna K, Strosberg J, Campos T, Shibata D. Phase I study of pre-operative continuous 5-FU and sorafenib with external radiation therapy in locally advanced rectal adenocarcinoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26861740 DOI: 10.1016/j.radonc.2016.01.018 |
0.409 |
|
| 2016 |
Doepker M, Baughen K, Brown RH, Kucera S, Lee J, Shridhar R, Meredith K. Accuracy of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting node positivity and metastatic disease in patients with gastrointestinal malignancies. Journal of Clinical Oncology. 34: 462-462. DOI: 10.1200/Jco.2016.34.4_Suppl.462 |
0.4 |
|
| 2016 |
Mellon EA, Hoffe SE, Frakes JM, Strom TJC, Springett GM, Shridhar R, Centeno B, Malafa MP, Hodul PJ. Predictors and survival for pathologic tumor response grade (TRG) in borderline resectable (BRPC) and locally advanced pancreatic cancer (LAPC) treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy (SBRT). Journal of Clinical Oncology. 34: 453-453. DOI: 10.1200/Jco.2016.34.4_Suppl.453 |
0.412 |
|
| 2016 |
Strom TJC, Hoffe SE, Frakes JM, Fulp WJ, Coppola D, Springett GM, Malafa MP, Harris CL, Eschrich SA, Shridhar R, Torres-Roca J. Genomically adjusted radiation dose to predict for survival with adjuvant radiation in resectable pancreatic cancer. Journal of Clinical Oncology. 34: 240-240. DOI: 10.1200/Jco.2016.34.4_Suppl.240 |
0.475 |
|
| 2016 |
Salem AI, Shridhar R, Hoffe SE, Almhanna K, Meredith K. Readmission after robotic Ivor Lewis esophagectomy: Earlier discharge, increased readmissions? Journal of Clinical Oncology. 34: 149-149. DOI: 10.1200/Jco.2016.34.4_Suppl.149 |
0.303 |
|
| 2016 |
Suker M, Beumer BR, Sadot E, Marthey L, Faris JE, Mellon EA, El-Rayes BF, Wang-Gillam A, Lacy J, Hosein PJ, Moorcraft SY, Conroy T, Hohla F, Allen P, Taieb J, ... ... Shridhar R, et al. FOLFIRINOX for locally advanced pancreatic cancer: A systematic review and patient-level meta-analysis The Lancet Oncology. DOI: 10.1016/S1470-2045(16)00172-8 |
0.355 |
|
| 2016 |
Suker M, Beumer BR, Sadot E, Marthey L, Faris JE, Mellon EA, El-Rayes B, Wang-Gillam A, Lacy J, Hosein PJ, Moorcraft SY, Conroy T, Hohla F, Allen P, Taieb J, ... ... Shridhar R, et al. A patient-level meta-analysis of FOLFIRINOX for locally advanced pancreatic cancer. Pancreatology. 16: S106-S107. DOI: 10.1016/J.Pan.2016.05.358 |
0.435 |
|
| 2015 |
Baksh K, Prithviraj G, Kim Y, Hoffe S, Shridhar R, Coppola D, Centeno B, Pimiento J, Meredith K, Almhanna K. Correlation Between Standardized Uptake Value in Preneoadjuvant and Postneoadjuvant Chemoradiotherapy and Tumor Regression Grade in Patients With Locally Advanced Esophageal Cancer. American Journal of Clinical Oncology. PMID 26703814 DOI: 10.1097/Coc.0000000000000258 |
0.408 |
|
| 2015 |
Rashid OM, Pimiento JM, Gamenthaler AW, Nguyen P, Ha TT, Hutchinson T, Springett G, Hoffe S, Shridhar R, Hodul PJ, Johnson BL, Illig K, Armstrong PA, Centeno BA, Fulp WJ, et al. Outcomes of a Clinical Pathway for Borderline Resectable Pancreatic Cancer. Annals of Surgical Oncology. PMID 26661409 DOI: 10.1245/S10434-015-5006-1 |
0.414 |
|
| 2015 |
Hickey R, Lewandowski RJ, Prudhomme T, Ehrenwald E, Baigorri B, Critchfield J, Kallini JR, Gabr A, Gorodetski B, Geschwind JF, Abbott A, Shridhar R, White SB, Rilling WS, Boyer B, et al. Y90 Radioembolization of Colorectal Hepatic Metastases using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26635340 DOI: 10.2967/Jnumed.115.166082 |
0.433 |
|
| 2015 |
Hayman TJ, Strom T, Springett GM, Balducci L, Hoffe SE, Meredith KL, Hodul P, Malafa M, Shridhar R. Outcomes of resected pancreatic cancer in patients age ≥70. Journal of Gastrointestinal Oncology. 6: 498-504. PMID 26487943 DOI: 10.3978/J.Issn.2078-6891.2015.038 |
0.459 |
|
| 2015 |
Blackham AU, Yue B, Almhanna K, Saeed N, Fontaine JP, Hoffe S, Shridhar R, Frakes J, Coppola D, Pimiento JM. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response. Journal of Surgical Oncology. 112: 597-602. PMID 26394724 DOI: 10.1002/Jso.24050 |
0.449 |
|
| 2015 |
Strom T, Hoffe SE, Fulp W, Frakes J, Coppola D, Springett GM, Malafa MP, Harris CL, Eschrich SA, Torres-Roca JF, Shridhar R. Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 117: 159-64. PMID 26235848 DOI: 10.1016/J.Radonc.2015.07.018 |
0.504 |
|
| 2015 |
Ahmed KA, Fulp WJ, Berglund AE, Hoffe SE, Dilling TJ, Eschrich SA, Shridhar R, Torres-Roca JF. Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection. International Journal of Radiation Oncology, Biology, Physics. 92: 837-42. PMID 25838188 DOI: 10.1016/J.Ijrobp.2015.01.036 |
0.408 |
|
| 2015 |
Abbott AM, Kim R, Hoffe SE, Arslan B, Biebel B, Choi J, El-Haddad G, Kis B, Sweeney J, Meredith KL, Almhanna K, Strosberg J, Shibata D, Fulp WJ, Shridhar R. Outcomes of Therasphere Radioembolization for Colorectal Metastases. Clinical Colorectal Cancer. PMID 25795047 DOI: 10.1016/J.Clcc.2015.02.002 |
0.456 |
|
| 2015 |
Mellon EA, Hoffe SE, Springett GM, Frakes JM, Strom TJ, Hodul PJ, Malafa MP, Chuong MD, Shridhar R. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma. Acta Oncologica (Stockholm, Sweden). 54: 979-85. PMID 25734581 DOI: 10.1200/Jco.2015.33.3_Suppl.360 |
0.472 |
|
| 2015 |
Almhanna K, Hoffe S, Strosberg J, Dinwoodie W, Meredith K, Shridhar R. Concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil (5-FU) and cisplatin for locally advanced resectable esophageal cancer. Journal of Gastrointestinal Oncology. 6: 39-44. PMID 25642336 DOI: 10.3978/J.Issn.2078-6891.2014.101 |
0.457 |
|
| 2015 |
Strom TJ, Klapman JB, Springett GM, Meredith KL, Hoffe SE, Choi J, Hodul P, Malafa MP, Shridhar R. Comparative long-term outcomes of upfront resected pancreatic cancer after preoperative biliary drainage. Surgical Endoscopy. 29: 3273-81. PMID 25631110 DOI: 10.1007/S00464-015-4075-3 |
0.472 |
|
| 2015 |
Shridhar R, Shibata D, Chan E, Thomas CR. Anal cancer: current standards in care and recent changes in practice. Ca: a Cancer Journal For Clinicians. 65: 139-62. PMID 25582527 DOI: 10.3322/Caac.21259 |
0.413 |
|
| 2015 |
Frakes JM, Strom T, Springett GM, Hoffe SE, Balducci L, Hodul P, Malafa MP, Shridhar R. Resected pancreatic cancer outcomes in the elderly. Journal of Geriatric Oncology. 6: 127-32. PMID 25555451 DOI: 10.1016/J.Jgo.2014.11.005 |
0.442 |
|
| 2015 |
Freilich J, Hoffe SE, Almhanna K, Dinwoodie W, Yue B, Fulp W, Meredith KL, Shridhar R. Comparative outcomes for three-dimensional conformal versus intensity-modulated radiation therapy for esophageal cancer Diseases of the Esophagus. 28: 352-357. PMID 24635657 DOI: 10.1111/dote.12203 |
0.377 |
|
| 2015 |
Saeed N, Doepker M, Shridhar R, Weber J, Hoffe SE, Almhanna K, Meredith KL. Association of AKT expression with degree of pathologic response in patients with esophageal cancer undergoing neoadjuvant therapy. Journal of Clinical Oncology. 33: 89-89. DOI: 10.1200/Jco.2015.33.3_Suppl.89 |
0.396 |
|
| 2015 |
Prithviraj GK, Jiang K, Zhao X, Chen D, Campos T, Shridhar R, Hoffe SE, Almhanna K, Shibata D, Kim RD. Preoperative infusional 5-FU and sorafenib with external radiation therapy in locally advanced rectal cancer: Results of a phase I study. Journal of Clinical Oncology. 33: 683-683. DOI: 10.1200/Jco.2015.33.3_Suppl.683 |
0.439 |
|
| 2015 |
Ahmed KA, Fulp WJ, Berglund AE, Hoffe SE, Dilling TJ, Eschrich SA, Shridhar R, Torres-Roca J. Differences between colon cancer primaries and metastases utilizing a molecular assay for tumor radiosensitivity and implications for potential oligometastatic SBRT patient selection. Journal of Clinical Oncology. 33: 569-569. DOI: 10.1200/Jco.2015.33.3_Suppl.569 |
0.404 |
|
| 2015 |
Kothari N, Kim RD, Springett GM, Hoffe SE, Almhanna K, Hodul PJ, Pimiento JM, Malafa MP, Fulp WJ, Zhao X, Shridhar R. Surgery and adjuvant therapy in gallbladder cancer: A single-institution experience. Journal of Clinical Oncology. 33: 405-405. DOI: 10.1200/Jco.2015.33.3_Suppl.405 |
0.508 |
|
| 2015 |
Strom TJC, Hoffe SE, Coppala D, Springett GM, Malafa MP, Eschrich SA, Torres-Roca J, Shridhar R. Radiosensensitivity index prognostic for survival with adjuvant radiation in resectable pancreatic cancer. Journal of Clinical Oncology. 33: 398-398. DOI: 10.1200/Jco.2015.33.3_Suppl.398 |
0.523 |
|
| 2015 |
Abbott AM, Hoffe SE, Strosberg JR, Almhanna K, Biebel B, Choi J, El-Haddad G, Kis B, Sweeney J, Fulp WJ, Shridhar R. Outcomes of therasphere radioembolization for neuroendocrine metastases. Journal of Clinical Oncology. 33: 371-371. DOI: 10.1200/Jco.2015.33.3_Suppl.371 |
0.397 |
|
| 2015 |
Mahipal A, Sajjad MZ, Denson A, Shridhar R, Springett GM, Batra S. Radiotherapy in locally advanced pancreatic cancer: SEER experience. Journal of Clinical Oncology. 33: 364-364. DOI: 10.1200/Jco.2015.33.3_Suppl.364 |
0.494 |
|
| 2015 |
Doepker M, Abbott AM, Shridhar R, Hoffe SE, Almhanna K, Meredith KL. Effect of neoadjuvant therapy on the risk for atrial fibrillation in patients undergoing esophagectomy. Journal of Clinical Oncology. 33: 210-210. DOI: 10.1200/Jco.2015.33.3_Suppl.210 |
0.366 |
|
| 2015 |
Abbott AM, Doepker M, Shridhar R, Hoffe SE, Almhanna K, Meredith KL. Outcomes associated with minimally invasive esophagectomy techniques. Journal of Clinical Oncology. 33: 171-171. DOI: 10.1200/Jco.2015.33.3_Suppl.171 |
0.363 |
|
| 2015 |
Prithviraj GK, Baksh K, Fulp W, Meredith K, Hoffe S, Shridhar R, Almhanna K. Carboplatin and paclitaxel as first-line treatment of unresectable or metastatic esophageal or gastric cancer Diseases of the Esophagus. 28: 782-787. DOI: 10.1200/Jco.2014.32.3_Suppl.140 |
0.443 |
|
| 2015 |
Shah J, Choi J, El-Haddad GE, Sweeney J, Biebel B, Spiess PE, Gupta S, Fishman MN, Hoffe SE, Shridhar R, Kis B. Hepatic yttrium-90 radioembolization treatment of patients with liver dominant metastatic renal cell cancer - the Moffitt experience Journal of Vascular and Interventional Radiology. 26. DOI: 10.1016/J.Jvir.2014.12.514 |
0.341 |
|
| 2015 |
Hickey RM, Prudhomme TR, Ehrenwald E, Critchfield JJ, Gorodetski B, Geschwind JH, Abbott AM, Shridhar R, White SB, Rilling WS, Kauffmann S, Kwan SW, Padia SA, Lewandowski RJ, Salem R. Y90 radioembolization of hepatic metastases of colorectal cancer using glass microspheres: survival and safety outcomes from a multicenter review of 531 patients Journal of Vascular and Interventional Radiology. 26. DOI: 10.1016/J.Jvir.2014.12.034 |
0.317 |
|
| 2015 |
Chuong M, Zhang H, Wang J, Latifi K, Saeed N, Tan S, Choi W, Hoffe S, Shridhar R, Lu W. Analytics for Progression Free Survival and Distant Metastasis Prediction of Anal Cancer Patients After Chemoradiation Therapy Using Spatial Temporal FDG-PET/CT Features International Journal of Radiation Oncology*Biology*Physics. 93: E158-E159. DOI: 10.1016/J.Ijrobp.2015.07.954 |
0.373 |
|
| 2014 |
Shridhar R, Hoffe SE, Meredith KL, Fontaine J, Fulp WJ, Almhanna K. Is it time for quality time? Intensive medical oncology follow-up during treatment for esophageal adenocarcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 29. PMID 28141440 DOI: 10.1200/Jco.2014.32.30_Suppl.29 |
0.446 |
|
| 2014 |
Shridhar R, Freilich J, Hoffe SE, Almhanna K, Fulp WJ, Yue B, Karl RC, Meredith K. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus. Annals of Surgical Oncology. 21: 3744-50. PMID 24854492 DOI: 10.1245/S10434-014-3795-2 |
0.499 |
|
| 2014 |
Hoffe S, Rao N, Shridhar R. Neoadjuvant vs adjuvant therapy for resectable pancreatic cancer: the evolving role of radiation. Seminars in Radiation Oncology. 24: 113-25. PMID 24635868 DOI: 10.1016/J.Semradonc.2013.11.002 |
0.48 |
|
| 2014 |
Wong J, Rahman S, Saeed N, Lin HY, Almhanna K, Shridhar R, Hoffe S, Meredith KL. Effect of body mass index in patients undergoing resection for gastric cancer: a single center US experience. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 18: 505-11. PMID 24443204 DOI: 10.1200/Jco.2013.31.4_Suppl.25 |
0.402 |
|
| 2014 |
Mellon EA, Springett GM, Hoffe SE, Hodul P, Malafa MP, Meredith KL, Fulp WJ, Zhao X, Shridhar R. Adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy. Cancer. 120: 1171-7. PMID 24390779 DOI: 10.1002/Cncr.28543 |
0.47 |
|
| 2014 |
Opfermann KJ, Wahlquist AE, Garrett-Mayer E, Shridhar R, Cannick L, Marshall DT. Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data. American Journal of Clinical Oncology. 37: 112-6. PMID 23211221 DOI: 10.1097/Coc.0B013E31826E0570 |
0.408 |
|
| 2014 |
Abbott AM, Strom TJC, Saeed N, Shridhar R, Hoffe SE, Almhanna K, Meredith KL. Robotic-assisted Ivor-Lewis esophagectomy in the elderly patient. Journal of Clinical Oncology. 32: 93-93. DOI: 10.1200/Jco.2014.32.3_Suppl.93 |
0.33 |
|
| 2014 |
Strom TJC, Hoffe SE, Vignesh S, Klapman J, Harris CL, Choi J, Springett GM, Meredith KL, Hodul PJ, Malafa MP, Shridhar R. Overall survival with preoperative biliary drainage in patients with resectable pancreatic cancer. Journal of Clinical Oncology. 32: 314-314. DOI: 10.1200/Jco.2014.32.3_Suppl.314 |
0.475 |
|
| 2014 |
Mellon EA, Springett GM, Hoffe SE, Hodul PJ, Malafa MP, Meredith K, Fulp WJ, Zhao X, Weber J, Shridhar R. Survival benefits of adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy. Journal of Clinical Oncology. 32: 263-263. DOI: 10.1200/Jco.2014.32.3_Suppl.263 |
0.499 |
|
| 2014 |
Shridhar R, Freilich J, Hoffe SE, Almhanna K, Fulp WJ, Yue B, Meredith KL. Survival impact of esophagectomy after chemoradiation for adenocarcinoma of the esophagus. Journal of Clinical Oncology. 32: 132-132. DOI: 10.1200/Jco.2014.32.3_Suppl.132 |
0.451 |
|
| 2014 |
Thau MR, Strom TJC, Almhanna K, Saeed N, Hoffe SE, Shridhar R, Karl RC, Meredith KL. Effect of body mass index on operative complications after robotic-assisted Ivor-Lewis esophagogastrostomy: Retrospective analysis of 133 cases at a single high-volume tertiary care center. Journal of Clinical Oncology. 32: 109-109. DOI: 10.1200/Jco.2014.32.3_Suppl.109 |
0.331 |
|
| 2014 |
Kim R, Jiang K, Zhao X, Chen D, Campos T, Hoffe S, Shridhar R, Shibata D. Abstract CT407: Phase I study of preoperative continuous 5-fu and sorafenib with external radiation therapy in locally advanced rectal adenocarcinoma Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Ct407 |
0.424 |
|
| 2014 |
Rao N, Shridhar R, Hoffe SE. Late effects of pelvic radiation for rectal cancer and implications for survivorship Seminars in Colon and Rectal Surgery. 25: 38-43. DOI: 10.1053/J.Scrs.2013.09.008 |
0.42 |
|
| 2013 |
Rao NG, Han G, Greene JN, Tanvetyanon T, Kish JA, De Conti RC, Chuong MD, Shridhar R, Biagioli MC, Caudell JJ, Trotti AM. Effect of prophylactic fluconazole on oral mucositis and candidiasis during radiation therapy for head-and-neck cancer. Practical Radiation Oncology. 3: 229-33. PMID 24674369 DOI: 10.1016/J.Prro.2012.05.008 |
0.422 |
|
| 2013 |
Fernandez DC, Hoffe SE, Barthel JS, Vignesh S, Klapman JB, Harris C, Almhanna K, Biagioli MC, Meredith KL, Feygelman V, Rao NG, Shridhar R. Stability of endoscopic ultrasound-guided fiducial marker placement for esophageal cancer target delineation and image-guided radiation therapy. Practical Radiation Oncology. 3: 32-9. PMID 24674261 DOI: 10.1016/J.Prro.2012.02.006 |
0.394 |
|
| 2013 |
Wong J, Rahman S, Saeed N, Lin HY, Almhanna K, Shridhar R, Hoffe S, Meredith KL. Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 17: 2059-66. PMID 24129828 DOI: 10.1007/S11605-013-2380-5 |
0.35 |
|
| 2013 |
Shridhar R, Imani-Shikhabadi R, Davis B, Streeter OA, Thomas CR. Curative treatment of esophageal cancer; an evidenced based review. Journal of Gastrointestinal Cancer. 44: 375-84. PMID 23824628 DOI: 10.1007/S12029-013-9511-9 |
0.397 |
|
| 2013 |
Wong J, Weber J, Almhanna K, Hoffe S, Shridhar R, Karl R, Meredith KL. Extent of lymphadenectomy does not predict survival in patients treated with primary esophagectomy. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 17: 1562-8; discussion 1. PMID 23818125 DOI: 10.1007/S11605-013-2259-5 |
0.486 |
|
| 2013 |
Shridhar R, Weber J, Hoffe SE, Almhanna K, Karl R, Meredith K. Adjuvant radiation therapy and lymphadenectomy in esophageal cancer: a SEER database analysis. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 17: 1339-45. PMID 23749498 DOI: 10.1007/S11605-013-2192-7 |
0.444 |
|
| 2013 |
Chuong MD, Freilich JM, Hoffe SE, Fulp W, Weber JM, Almhanna K, Dinwoodie W, Rao N, Meredith KL, Shridhar R. Intensity-Modulated Radiation Therapy vs. 3D Conformal Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal. Gastrointestinal Cancer Research : Gcr. 6: 39-45. PMID 23745158 DOI: 10.1200/Jco.2013.31.4_Suppl.494 |
0.489 |
|
| 2013 |
Chuong MD, Fernandez DC, Shridhar R, Hoffe SE, Saini A, Hunt D, Meredith KL, Biagioli MC. High-dose-rate endorectal brachytherapy for locally advanced rectal cancer in previously irradiated patients. Brachytherapy. 12: 457-62. PMID 23707855 DOI: 10.1016/J.Brachy.2012.11.003 |
0.457 |
|
| 2013 |
Hernandez JM, Dimou F, Weber J, Almhanna K, Hoffe S, Shridhar R, Karl R, Meredith K. Defining the learning curve for robotic-assisted esophagogastrectomy. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 17: 1346-51. PMID 23690208 DOI: 10.1007/S11605-013-2225-2 |
0.314 |
|
| 2013 |
Melis M, Weber J, Shridhar R, Hoffe S, Almhanna K, Karl RC, Meredith KL. Body mass index and perioperative complications after oesophagectomy for adenocarcinoma: a systematic database review. Bmj Open. 3. PMID 23645908 DOI: 10.1136/Bmjopen-2012-001336 |
0.369 |
|
| 2013 |
Shridhar R, Hoffe SE, Almhanna K, Weber JM, Chuong MD, Karl RC, Meredith K. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy. Annals of Surgical Oncology. 20: 3038-43. PMID 23625142 DOI: 10.1245/S10434-013-2988-4 |
0.374 |
|
| 2013 |
Wong JY, Shridhar R, Almhanna K, Hoffe SE, Karl RC, Meredith KL. The impact of body mass index on esophageal cancer. Cancer Control : Journal of the Moffitt Cancer Center. 20: 138-43. PMID 23571704 DOI: 10.1177/107327481302000207 |
0.32 |
|
| 2013 |
Vignesh S, Hoffe SE, Meredith KL, Shridhar R, Almhanna K, Gupta AK. Endoscopic therapy of neoplasia related to Barrett's esophagus and endoscopic palliation of esophageal cancer. Cancer Control : Journal of the Moffitt Cancer Center. 20: 117-29. PMID 23571702 DOI: 10.1177/107327481302000205 |
0.366 |
|
| 2013 |
Almhanna K, Meredith KL, Hoffe SE, Shridhar R, Coppola D. Targeting the human epidermal growth factor receptor 2 in esophageal cancer. Cancer Control : Journal of the Moffitt Cancer Center. 20: 111-6. PMID 23571701 DOI: 10.1177/107327481302000204 |
0.439 |
|
| 2013 |
Shridhar R, Almhanna K, Meredith KL, Biagioli MC, Chuong MD, Cruz A, Hoffe SE. Radiation therapy and esophageal cancer. Cancer Control : Journal of the Moffitt Cancer Center. 20: 97-110. PMID 23571700 DOI: 10.1177/107327481302000203 |
0.388 |
|
| 2013 |
Almhanna K, Shridhar R, Meredith KL. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: is there a standard of care? Cancer Control : Journal of the Moffitt Cancer Center. 20: 89-96. PMID 23571699 DOI: 10.1177/107327481302000202 |
0.417 |
|
| 2013 |
Chuong MD, Springett GM, Freilich JM, Park CK, Weber JM, Mellon EA, Hodul PJ, Malafa MP, Meredith KL, Hoffe SE, Shridhar R. Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated. International Journal of Radiation Oncology, Biology, Physics. 86: 516-22. PMID 23562768 DOI: 10.1016/J.Ijrobp.2013.02.022 |
0.505 |
|
| 2013 |
Pimiento JM, Weber J, Hoffe SE, Shridhar R, Almhanna K, Vignesh S, Karl RC, Meredith KL. Outcomes associated with surgery for T4 esophageal cancer. Annals of Surgical Oncology. 20: 2706-12. PMID 23504118 DOI: 10.1245/S10434-013-2885-X |
0.425 |
|
| 2013 |
Shridhar R, Almhanna K, Hoffe SE, Fulp W, Weber J, Chuong MD, Meredith KL. Increased survival associated with surgery and radiation therapy in metastatic gastric cancer: a Surveillance, Epidemiology, and End Results database analysis. Cancer. 119: 1636-42. PMID 23361968 DOI: 10.1002/Cncr.27927 |
0.477 |
|
| 2013 |
Shridhar R, Freilich J, Hoffe S, Fulp WJ, Chuong M, Almhanna K, Karl RC, Meredith K. Survival in patients with esophageal cancer treated with surgery after chemoradiotherapy. Journal of Clinical Oncology. 31: 98-98. DOI: 10.1200/Jco.2013.31.4_Suppl.98 |
0.455 |
|
| 2013 |
Freilich J, Chuong M, Yue B, Fulp WJ, Abuodeh YA, Almhanna K, Meredith K, Karl RC, Hoffe S, Shridhar R. Comparative outcomes for 3D conformal versus intensity modulated radiation therapy for esophageal cancer. Journal of Clinical Oncology. 31: 76-76. DOI: 10.1200/Jco.2013.31.4_Suppl.76 |
0.46 |
|
| 2013 |
Ashraf N, Razzaque S, Creelan BC, Chavez JC, Shibata D, Hoffe S, Shridhar R, Kim RD. Positron emission tomography-computed tomography (PET-CT) for the assessment of pathologic response to neoadjuvant chemoradiotherapy in rectal adenocarcinoma. Journal of Clinical Oncology. 31: 537-537. DOI: 10.1200/Jco.2013.31.4_Suppl.537 |
0.344 |
|
| 2013 |
Figura N, Cruz A, Mellon EA, Chuong M, Hoffe S, Springett GM, Saeed N, Hodul PJ, Malafa MP, Balducci L, Shridhar R. Efficacy and feasibility of chemotherapy and radiation therapy for borderline resectable pancreatic cancer in elderly patients. Journal of Clinical Oncology. 31: 320-320. DOI: 10.1200/Jco.2013.31.4_Suppl.320 |
0.473 |
|
| 2013 |
Cruz A, Chen D, Fulp WJ, Chuong M, Hoffe S, Shridhar R, Rao NG, Hodul PJ, Malafa MP, Figura N, Eikman E, Springett GM. Pretreatment metabolic tumor volume (MTV) as a predictor of survival in borderline resectable pancreatic cancers treated with neoadjuvant therapy. Journal of Clinical Oncology. 31: 310-310. DOI: 10.1200/Jco.2013.31.4_Suppl.310 |
0.431 |
|
| 2013 |
Chuong M, Mellon EA, Hoffe S, Shridhar R, Springett GM, Hodul PJ, Malafa MP, Figura N, Centeno B. Rates of pathologic complete or near complete response following neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer. Journal of Clinical Oncology. 31: 221-221. DOI: 10.1200/Jco.2013.31.4_Suppl.221 |
0.516 |
|
| 2013 |
Wong J, Rahman S, Saeed N, Lin H, Almhanna K, Shridhar R, Hoffe S, Meredith K. Prognostic impact of lymph node retrieval and ratio in gastric cancer: A single-center U.S. experience. Journal of Clinical Oncology. 31: 17-17. DOI: 10.1200/Jco.2013.31.4_Suppl.17 |
0.439 |
|
| 2013 |
McTyre E, Freilich J, Chuong M, Fulp WJ, Almhanna K, Meredith K, Hoffe S, Shridhar R. A comparison of outcomes for 3D conformal versus intensity modulated radiation therapy in postoperative gastric cancer. Journal of Clinical Oncology. 31: 139-139. DOI: 10.1200/Jco.2013.31.4_Suppl.139 |
0.489 |
|
| 2013 |
Almhanna K, Hoffe S, Shridhar R, Strosberg JR, Dinwoodie WR, Meredith K. Concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil (5 FU) and cisplatin for locally advanced resectable esophageal cancer: A retrospective study. Journal of Clinical Oncology. 31: 119-119. DOI: 10.1200/Jco.2013.31.4_Suppl.119 |
0.42 |
|
| 2013 |
Smith FO, Hoffe S, Almhanna K, Shridhar R, Karl RC, Meredith K. Robotic-assisted Ivor Lewis esophagectomy with or without neoadjuvant chemoradiation therapy for esophageal cancer. Journal of Clinical Oncology. 31: 117-117. DOI: 10.1200/Jco.2013.31.4_Suppl.117 |
0.48 |
|
| 2013 |
Shridhar R, Almhanna K, Hoffe S, Fulp WJ, Weber J, Chuong M, Meredith K. Association of increased survival with surgery and radiation therapy in metastatic gastric cancer: A SEER database analysis. Journal of Clinical Oncology. 31: 109-109. DOI: 10.1200/Jco.2013.31.4_Suppl.109 |
0.452 |
|
| 2012 |
Cruz A, Chuong MD, Weber JM, Eikman E, Lomas H, Pimiento JM, Almhanna K, Shridhar R, Hoffe SE, Meredith K. Post-radiation metabolic tumor volume (MTV) and survival in esophageal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 9. PMID 27983435 DOI: 10.1200/Jco.2012.30.4_Suppl.9 |
0.449 |
|
| 2012 |
De La Fuente SG, Weber JM, Hoffe SE, Shridhar R, Almhanna K, Karl RC, Meredith K. Safety and oncologic outcomes of robotic-assisted esophagogastrectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 93. PMID 27983402 DOI: 10.1200/Jco.2012.30.4_Suppl.93 |
0.381 |
|
| 2012 |
Pimiento JM, Boutrid H, Weber JM, Razzaque S, Farma JM, Kim RD, Hodul PJ, Shridhar R, Hoffe SE, Almhanna K, Chuong MD, Chen DT, Springett GM, Eikman E, Klapman J, et al. Low (18)f-fluorodeoxyglucose uptake on positron emission tomography as a prognostic factor for stage I and II pancreatic cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 159. PMID 27982901 DOI: 10.1200/Jco.2012.30.4_Suppl.159 |
0.311 |
|
| 2012 |
Almhanna K, Weber JM, Shridhar R, Hoffe SE, Karl RC, Meredith K. Effect of lymphadenectomy on survival in patients with esophageal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 65. PMID 27982851 DOI: 10.1200/Jco.2012.30.4_Suppl.65 |
0.473 |
|
| 2012 |
Pimiento JM, Hutchinson T, Weber JM, Patel MR, Hodul PJ, Chuong MD, Springett GM, Hoffe SE, Karl RC, Centeno B, Klapman J, Shridhar R, Chen DT, Malafa MP. Multimodality therapy for borderline resectable pancreatic cancer: A single-institution experience. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 280. PMID 27982804 DOI: 10.1200/Jco.2012.30.4_Suppl.280 |
0.438 |
|
| 2012 |
Vijapura C, Shridhar R, Weber JM, Hoffe SE, Deneve JL, Barthel JS, Karl RC, Meredith K, Almhanna K. Prognostic significance of lymphadenectomy in patients with esophageal cancer receiving neoadjuvant chemoradiation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 87. PMID 27982792 DOI: 10.1200/Jco.2012.30.4_Suppl.87 |
0.501 |
|
| 2012 |
Shridhar R, Hayman T, Hoffe SE, Weber J, Almhanna K, Chuong M, Karl RC, Meredith KL. Body mass index and survival in esophageal adenocarcinoma treated with chemoradiotherapy followed by esophagectomy. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 16: 1296-302. PMID 22399271 DOI: 10.1007/S11605-012-1843-4 |
0.339 |
|
| 2012 |
Dittrick GW, Weber JM, Shridhar R, Hoffe S, Melis M, Almhanna K, Barthel J, McLoughlin J, Karl RC, Meredith KL. Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy. Annals of Surgical Oncology. 19: 1678-84. PMID 22045465 DOI: 10.1245/S10434-011-2078-4 |
0.491 |
|
| 2012 |
Shridhar R, Dombi GW, Weber J, Hoffe SE, Meredith K, Konski A. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis. American Journal of Clinical Oncology. 35: 216-21. PMID 21378540 DOI: 10.1097/Coc.0B013E31820Dbf08 |
0.462 |
|
| 2012 |
Lomas H, Hoffe S, Weber J, Dilling T, Chuong, Almhanna K, Karl R, Meredith K, Shridhar R. Post Chemoradiation PET SUV is highly Predictive of Overall Survival in Esophageal Cancer Journal of Nuclear Medicine and Radiation Therapy. 3: 1-6. DOI: 10.4172/2155-9619.1000125 |
0.474 |
|
| 2012 |
Yamamoto M, Weber J, Shridhar R, Hoffe S, Almhanna K, Karl R, Meredith KL. Tu2066 AKT Expression is Associated With Degree of Pathologic Response in Adenocarcinoma of the Esophagus Treated With Neoadjuvant Therapy Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)64313-3 |
0.302 |
|
| 2012 |
Wong J, Weber J, Almhanna K, Hoffe S, Shridhar R, Meredith KL. 1011 Extent of Lymphadenectomy Does Not Predict Survival in Patients Treated With Primary Esophagectomy Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)64063-3 |
0.364 |
|
| 2012 |
Shridhar R, Weber J, Hoffe S, Almhanna K, Karl R, Meredith KL. 1010 Adjuvant Radiation Therapy and Lymph Node Dissection in Esophageal Cancer: A SEER Database Analysis Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)64062-1 |
0.39 |
|
| 2012 |
Shridhar R, Chuong MD, Weber J, Freilich J, Almhanna K, Coppola D, Dinwoodie W, Dilling TJ, Fernandez D, Karl RC, Meredith KL, Hoffe SE. Outcomes of definitive or preoperative IMRT chemoradiation for esophageal cancer Journal of Radiation Oncology. 1: 347-354. DOI: 10.1007/S13566-012-0048-5 |
0.451 |
|
| 2012 |
Chuong MD, Springett GM, Weber J, Klapman J, Vignesh S, Hodul PJ, Malafa MP, Leuthold S, Hoffe SE, Shridhar R. Induction gemcitabine-based chemotherapy and neoadjuvant stereotactic body radiation therapy achieve high margin-negative resection rates for borderline resectable pancreatic cancer Journal of Radiation Oncology. 1: 273-281. DOI: 10.1007/S13566-012-0039-6 |
0.478 |
|
| 2012 |
Chuong MD, Hoffe SE, Weber J, Freilich JM, Lomas H, Almhanna K, Dessureault S, Dinwoodie WR, Kim R, Meredith KL, Strosberg JR, Shibata D, Rao NG, Biagioli MC, Shridhar R. Outcomes of anal cancer treated with definitive IMRT-based chemoradiation Journal of Radiation Oncology. 1: 165-172. DOI: 10.1007/S13566-012-0029-8 |
0.382 |
|
| 2011 |
Chuong MD, Hayman TJ, Patel MR, Russell MS, Malafa MP, Hodul PJ, Springett GM, Choi J, Shridhar R, Hoffe SE. Comparison of 1-, 2-, and 3-Dimensional Tumor Response Assessment After Neoadjuvant GTX-RT in Borderline-Resectable Pancreatic Cancer. Gastrointestinal Cancer Research : Gcr. 4: 128-34. PMID 22368736 |
0.365 |
|
| 2011 |
Shridhar R, Dombi GW, Finkelstein SE, Meredith KL, Hoffe SE. Improved survival in patients with lymph node-positive gastric cancer who received preoperative radiation: an analysis of the Surveillance, Epidemiology, and End Results database. Cancer. 117: 3908-16. PMID 21365627 DOI: 10.1002/Cncr.25995 |
0.461 |
|
| 2011 |
Melis M, Weber JM, McLoughlin JM, Siegel EM, Hoffe S, Shridhar R, Turaga KK, Dittrick G, Dean EM, Karl RC, Meredith KL. An elevated body mass index does not reduce survival after esophagectomy for cancer. Annals of Surgical Oncology. 18: 824-31. PMID 20865331 DOI: 10.1245/S10434-010-1336-1 |
0.383 |
|
| 2011 |
Chuong MD, Hoffe SE, Shridhar R, Biagioli MC. Preoperative HDR Brachytherapy for Rectal Adenocarcinoma in Previously Irradiated Patients: The Initial Moffitt Cancer Center Experience Brachytherapy. 10. DOI: 10.1016/J.Brachy.2011.02.030 |
0.456 |
|
| 2011 |
Chuong MD, Hoffe SE, Shridhar R, Biagioli MC. Preoperative Concomittant Chemotherapy/EBRT With HDR Brachytherapy Boost for Rectal Adenocarcinoma: The Initial Moffitt Cancer Center Experience Brachytherapy. 10. DOI: 10.1016/J.Brachy.2011.02.029 |
0.453 |
|
| 2010 |
Hoffe SE, Shridhar R, Biagioli MC. Radiation therapy for rectal cancer: current status and future directions. Cancer Control : Journal of the Moffitt Cancer Center. 17: 25-34. PMID 20010516 DOI: 10.1177/107327481001700104 |
0.452 |
|
| 2009 |
Shridhar R, Bolton S, Joiner MC, Forman JD. Dose escalation using a hypofractionated, intensity-modulated radiation therapy boost for localized prostate cancer: preliminary results addressing concerns of high or low alpha/beta ratio. Clinical Genitourinary Cancer. 7: E52-7. PMID 19815482 DOI: 10.3816/Cgc.2009.N.024 |
0.325 |
|
| 2009 |
Shridhar R, Dombi GW. Outcomes of Postoperative Radiation Therapy in Gastric Cancer from the SEER Database International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.642 |
0.409 |
|
| 2008 |
Chien J, Narita K, Rattan R, Giri S, Shridhar R, Staub J, Beleford D, Lai J, Roberts LR, Molina J, Kaufmann SH, Prendergast GC, Shridhar V. A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation Oncogene. 27: 7223-7234. PMID 18806825 DOI: 10.1038/Onc.2008.360 |
0.325 |
|
| 2006 |
Song J, Jie C, Polk P, Shridhar R, Clair T, Zhang J, Yin L, Keppler D. The candidate tumor suppressor CST6 alters the gene expression profile of human breast carcinoma cells: down-regulation of the potent mitogenic, motogenic, and angiogenic factor autotaxin. Biochemical and Biophysical Research Communications. 340: 175-82. PMID 16356477 DOI: 10.1016/J.Bbrc.2005.11.171 |
0.304 |
|
| 2004 |
Zhang J, Shridhar R, Dai Q, Song J, Barlow SC, Yin L, Sloane BF, Miller FR, Meschonat C, Li BD, Abreo F, Keppler D. Cystatin m: a novel candidate tumor suppressor gene for breast cancer. Cancer Research. 64: 6957-64. PMID 15466187 DOI: 10.1158/0008-5472.Can-04-0819 |
0.54 |
|
| 2004 |
Shridhar R, Zhang J, Song J, Booth BA, Kevil CG, Sotiropoulou G, Sloane BF, Keppler D. Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells. Oncogene. 23: 2206-15. PMID 14676833 DOI: 10.1038/Sj.Onc.1207340 |
0.523 |
|
| 2000 |
Shridhar R, Sloane BF, Keppler D. Inhibitors of Papain-Like Cysteine Peptidases in Cancer Handbook of Experimental Pharmacology. 140: 301-328. DOI: 10.1007/978-3-642-57092-6_16 |
0.517 |
|
| 1997 |
Shridhar V, Rivard S, Wang X, Shridhar R, Paisley C, Mullins C, Beirnat L, Dugan M, Sarkar F, Miller OJ, Vaitkevicius VK, Smith DI. Mutations in the arginine-rich protein gene (ARP) in pancreatic cancer Oncogene. 14: 2213-2216. PMID 9174057 DOI: 10.1038/Sj.Onc.1201054 |
0.313 |
|
| Show low-probability matches. |